The phase diagram data of 60 binary systems of drugs were evaluated with the aid of a computer-coupled phase diagram/thermodynamic analysis. Data for this analysis were obtained by an exhaustive literature search ͑110 references͒. Among the results of this analysis are the excess Gibbs energy of liquid and solid solution phases, and the thermodynamic properties of intermediate compounds. For each system a phase diagram was calculated; such calculated diagrams are thermodynamically consistent and are offered as the best constructions which can be deduced from available data.
Introduction
The biological activity of medicinal chemicals is a proper concern of health professionals and the pharmaceutical industry. This includes interactions between different substances simultaneously present in vivo. Many drugs are manufactured in solid tablet form, in which case crystal structure can influence tableting ability 1 and dissolution behavior. 2 Since many drugs can persist in one or more metastable solid modifications ͑polymorphism 3 ͒, the properties of these metastable forms also are important for predicting stability in storage. When two compounds are combined in solid form it is prudent to be aware of interactions in the solid state which may affect the final efficacy of the preparation. 4 In the tableting operation, pressure is applied to the solid mass, whose temperature may rise to a variable degree. If the two compounds form a simple eutectic, the physical mixture of eutectic composition may have properties different from those of a fused mass. 5 If an intermediate compound is formed, its stability must be ascertained. 6 The complex, upon ingestion, may or may not decompose to give the original components 7 and the complex itself may have pharmaceutical properties different from its component drugs. [8] [9] [10] The formation of a solid solution between a difficultly soluble substance and another drug may ameliorate the dissolution properties of the difficultly soluble compound. 11, 12 A number of methods have been used to investigate interactions between drug molecules in the solid state. Among them are: x-ray diffraction, absorption spectrophotometry ͓ultraviolet ͑UV͒, infrared ͑IR͔͒, thermogravimetric analysis, refractive index and differential thermal analysis 3, 13 ͑DTA͒. When applied to a binary drug system, DTA and differential scanning calorimetry ͑DSC͒ enable the phase diagram of the system to be obtained, including the following properties:
͑i͒ melting points and enthalpy of fusion of pure substances, eutectics and intermediate compounds ͑ii͒ determination of drug purity, 14 ͑iii͒ polymorphism, ͑iv͒ thermal stability, ͑v͒ glass transitions, and ͑vi͒ solid solubility.
Thermodynamic Analysis of Phase Diagrams
Although a number of binary phase diagrams of pharmaceutical substances have been measured and reported, both the quantity and quality of the data are highly variable. The experimental methods used have different strengths and weaknesses, and the reported phase diagrams are not always consistent with thermodynamic constraints arising from the condition of equilibrium. In the present work, a computercoupled phase diagram/thermodynamic analysis was used to calculate a phase diagram for each of 60 systems examined. This type of analysis uses available phase diagram and thermodynamic constraints and effects a correct thermodynamic smoothing of experimental data. Other results of this analysis include the deduction of excess Gibbs energies of solution phases and thermodynamic properties of intermediate compounds. The procedure has been applied with equal success to systems of molten salts, 15 organic compounds, 16, 17 metal oxides 18 and liquid crystals. 19 
Computer-Coupled Phase Diagram/ Thermodynamic Analysis
The thermodynamic basis of phase diagrams is well known. 20, 21 The analysis used here has been described previously; 15, 17 the principal features are summarized in what follows. The given data are those of the pure components and the liquidus, solidus, eutectic and peritectic temperature arrests. The computer program performs a simultaneous least-squares optimization of the thermodynamic and phase diagram data, resulting in expressions for the excess Gibbs energies of liquid and solid solution phases and thermodynamic properties of intermediate compounds ͑if any͒. With these data, a phase diagram is calculated and the invariant points of the system are deduced. The computer programs are available on-line 22 and also on microcomputer diskette ͑details available from the author͒.
Solid Solutions of Limited Solubility
As a general rule, systems of organic compounds do not exhibit solid solubility, principally because the crystalline structures of the components are usually incompatible. When there is no solid solution, the limiting liquidus slope near a pure component ͑say A͒ is given by 15, 17 ͑ dx A /dT ͒ liq ϭ⌬ fus H A /RT fus 2 , ͑1͒
where T fus is the melting point of component A and ⌬ fus H A is the enthalpy of fusion. The expression on the right hand side ͑RHS͒ is simply the reciprocal of the well-known freezing point depression constant and depends only on properties of the solvent. A similar expression holds for the other component. Equation ͑1͒ is useful in preliminary analysis of phase diagram data in suggesting the presence or absence of solid solubility or in the critical evaluation of experimental liquidus data. 17 Equation ͑1͒ is a necessary thermodynamic requirement for equilibrium phase diagrams, and all phase diagrams shown in the present work adhere to this constraint. In a few cases, solid solubility was included in the phase diagram in order to reproduce the experimental liquidus. The solid solution was assumed to be Henrian, i.e., the activity of the solvent was assumed to be unity and the solute was rep-891 891 THERMODYNAMIC PROPERTIES OF BINARY SYSTEMS OF DRUGS resented by a temperature-independent activity coefficient. 15, 17 In actuality, of course, these are approximations, but suffice for the purposes at hand.
Experimental Methods of Measurement
Various techniques were used to determine phase diagrams for the systems studied:
͑1͒ thermal analysis ͑cooling curves͒, ͑2͒ thaw-melt method, ͑3͒ DTA, DSC, ͑4͒ Kofler's contact ͑microthermal͒ method, ͑5͒ hot-stage microscope, and ͑6͒ light transmission.
All these are methods for detecting the solid-liquid phase change as a function of temperature and composition. Methods 1-5 have been described and evaluated. 4, 17, 21 In method 6, the phase change is registered automatically by the response of a photocell to transmitted light.
In the evaluation of phase diagram data from these methods, several considerations are pertinent: ͑i͒ supercooling, ͑ii͒ use of heating or cooling mode, ͑iii͒ visual or instrumental detection, and ͑iv͒ preparation of mixtures.
The same system, studied by different methods, may yield rather different results. 4 In the present work, experimental methods are stated in the discussion of every system and mention of experimental peculiarities is made and accounted for. Other supplementary experimental methods were: x-ray diffraction, microphotographic analysis and IR spectroscopy. Their purpose was generally to confirm features of the solid state ͑solid solutions, presence of compounds, etc.͒.
Polymorphism and Metastable States
Drugs, being organic compounds, may exist in one or more metastable solid states, in addition to the thermodynamically stable one. 3, 23 These states require a change of crystal structure in the solid in order to be transformed and in practice can persist for appreciable periods. Their melting points are often quite close to that of the stable form; these properties are potentially complicating factors in the interpretation of the results of thermal methods. Since their appearance and persistence are reproducible, experimental conditions can be established to minimize their effects. The phase diagrams considered in the present work deal only with thermodynamically stable states.
The method of preparation of samples for analysis by thermal methods has been found to be important for the establishment of an equilibrium phase diagram. For example, physical mixtures-however finely divided-showed metastable eutectics in thermal analytical methods. Prefused mixtures prepared by solvent evaporation were found to give more reproducible results. In the present work, only stable features are reproduced in phase diagrams, but experimental metastable ones are mentioned whenever they were reported.
It should be emphasized here that the effects of polymorphism in drug compounds are of great importance to pharmaceutical chemists, for evident practical reasons. The present analysis is limited to thermodynamically stable states because inclusion of metastable states would greatly enlarge the article and obscure the application of fundamental thermodynamic relationships.
Retrieval and Treatment of Data
Apart from Chemical Abstracts, some compilations 13, 23, 24 were useful in locating phase diagram data. Where the data were not tabulated, they were read off the published phase diagrams. Both liquidus and solidus data were retrieved, and are shown on the calculated phase diagrams. In general, eutectic data and congruent melting points of compounds were given somewhat more weight than other liquidus data in the optimization step, for stated reasons. 17 Where the data were sparse or contradictory, some prior decisions were made concerning the general shape or features of the phase diagram. These preliminary steps are explained in the evaluations of individual systems.
It is pertinent to add that the choice of systems examined was governed principally by the existence of phase diagram data amenable to a thermodynamic analysis of the present type. The phase diagrams are illustrative but not meant to be ''representative'' of any particular area of inquiry in pharmaceutical chemistry.
Properties of the Pure Substances
Evaluations of the present type require reliable data for melting points and enthalpies of fusion of the pure components. There are standard handbooks of melting points; 3, [25] [26] [27] [28] [29] information from these will be referred to henceforth as ''handbook data.'' For ethalpies of fusion, two sources were generally useful. 30, 31 In addition to these sources, melting point and enthalpy of fusion data were retrieved from individual articles; these are mentioned below for each substance considered. Table 1 presents the data adopted in the present work. Temperatures are quoted to the nearest 0.1°C, irrespective of source, since the precision of experimental phase diagram data does not warrant citation of hundredths of a degree. For similar reasons, only three significant figures were retained for enthalpies of fusion. The larger number of significant figures given for the entropy of fusion were used for accurate reproduction of adopted melting points; they have no further significance. In what follows, the given name of the drug is accompanied, in square brackets, by other information: formula, Chemical Abstracts Registry Number and other informal names ͑if any͒.
Acetanilide ͓C 8 H 9 NO; 103-84-4; Acetamide, N-phenyl-͔. The enthalpy of fusion was reported to be 32 30, 40 The enthalpy of fusion was reported 30,40 as 20.9 or 41 24 .0 kJ mol Ϫ1 .
Aminophenazone ͓C 13 H 17 N 3 O; 58-15-1; Pyrazole-3-one,  4-͑dimethylamino͒-1,2-dihydro-1,5-dimethyl-2-phenyl-;  aminopyrine, amidopyrine͔. The handbook melting point is  107-109°C, and a value 37,42-44 between 107 and 108°C was chosen. There is one value for the enthalpy of fusion. 45 4-Aminophenazone ͓C 11 H 13 N 3 O; 83-07-8; 3H-Pyrazol-3one, 4-amino-1,2-dihydro-1,5-dimethyl-2-phenyl-͔. Handbooks give 109°C as the melting point, but individual reports 35, 42, 45, 46 indicate a temperature closer to 108°C. There is one value for the enthalpy of fusion. 45 Anthranilic acid ͓C 7 H 7 NO 2 ; 118-92-3; Benzoic acid, 2-amino-͔. The handbook melting range is 144-148°C. A melting point in the lower range 30, 40 was chosen. The enthalpy of fusion is the mean of two values. 30, 40 Aspirin ͓C 9 H 8 O 4 ; 50-78-2; Benzoic acid, 2-͑acetyloxy͒-; Acetylsalicyclic acid͔. The handbook melting point is 135°C, although the freezing point is often quoted to be much lower. This was taken to be the correct value. 4, 47 There is no experimental value for the enthalpy of fusion, and so it was estimated ͑next section͒.
Barbital ͓C 8 H 12 N 2 O 3 ; 57-44-3; 2,4,6͑1H,3H,5H-Pyrimidinetrione, 5,5-diethyl-; Veronal, Barbitone͔. The handbook melting range is 188-192°C, and the adopted value 3, 5, 48 is close to 190°C. The enthalpy of fusion is 38 24.4 or 39 25 .0 kJ mol Ϫ1 .
Benzidine ͓C 12 H 12 N 2 ; 92-87-5; ͓1,1Ј-Biphenyl͔-4,4Ј-diamine͔. The handbook melting point is 128°C, and the adopted value is from a phase diagram study. 49 The enthalpy of fusion, from the same source, is 19.1 kJ mol Ϫ1 .
Benzocaine ͓C 9 H 11 O 2 ; 94-09-7; Benzoic acid, 4-amino-, ethyl ester; Parathesin͔. The melting range from handbook sources is 88-92°C. A more accurate value is close 32, 40, 50 to 90°C. The enthalpy of fusion lies in the range 32, 40, 50 22.0-23.6 kJ mol Ϫ1 .
Benzoic acid ͓C 7 H 6 O 2 ; 65-85-0͔. The chosen melting point 30, 40, 51 is close to the handbook value. The enthalpy of fusion is the mean of several determinations. 30, 40, 51, 52 Caffeine ͓C 8 H 10 N 4 O 2 ; 58-08-2; 1H-Purine-2,6-dione, 3,7dihydro-1,3,7-trimethyl-͔. Handbook data for the melting point lie in the range 235-238°C. A temperature near 236°C was adopted. 30, 35 The enthalpy of fusion 30 54 Since there is no experimental value for the enthalpy of fusion it was estimated ͑next section͒.
Estradiol benzoate ͓C 25 H 28 O 3 ; 50-50-0; Estra-1,3,5͑10͒triene-3,7-diol ͑17␤͒, 3-benzoate; Benztrone͔. Handbook melting point data indicate 188-196°C, and a value close to 192°C was adopted. 55, 56 The enthalpy of fusion is 32 
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Handbook melting point data give 126-128°C, and the adopted value is a mean from two sources. 55, 56 There is one value 55 for the enthalpy of fusion.
Ethinyl estradiol ͓C 20 H 24 O 2 ; 57-63-6; 19-Norpregna-1,3,5͑10͒-trien-20-yne-3,17-diol,͑17␣͒-͔. The melting point data according to handbooks are not consistent: 145-146°C or 182-184°C. The higher temperature is preferred. 54 The enthalpy of fusion was reported to be 32,54 22.4-28.1 kJ mol Ϫ1 .
Etofylline ͓C 9 H 12 N 4 O 3 ; 519-37-9; 1H-Purine-2,6-dione, 3,7-dihydro-7-͑2-hydroxyethyl͒-1,3-dimethyl-; Oxytheonyl͔. The handbook melting point is 158°C, but the value adopted is that from a phase diagram study. 57 There is no experimental value for the enthalpy of fusion, so it was estimated ͑next section͒.
Hydroquinone ͓C 6 H 6 O 2 ; 123-31-9; Benzene, 1,4dihydroxy-͔. The melting range is 172-179°C according to handbooks; a more accurate value was chosen from studies on the pure compound. 30, 58, 59 The enthalpy of fusion lies in the range 30,58,60 21.1-27.1 kJ mol Ϫ1 .
Indomethacin ͓C 19 H 16 ClNO 4 ; 53-86-1; 1H-Indole-3-acetic acid, 1-͑4-chlorophenyl͒-5-methoxy-2-methyl-͔. The handbook melting range is 156-162°C and the adopted value 61, 62 is close to 160°C. The enthalpy of fusion is 63 36 .1 or 32 37.7 kJ mol Ϫ1 .
Isonicotinamide ͓C 6 H 6 N 2 O; 1453-82-3; 4-Pyridinecarbox-amide͔. The handbook melting point is 155-156°C, and the adopted value was taken from a phase diagram study. 5 There is no experimental value for the enthalpy of fusion, so it was estimated ͑next section͒.
Khellin ͓C 14 H 12 O 5 ; 82-02-0; 5H-Furo͓3,2-g͔͓1͔benzopyran-5-one, 4,9-dimethoxy-7-methyl-; Amicardine͔. The handbook melting range is 153-155°C, and the true melting point is probably the lower value. [64] [65] [66] There is one value 65 for the enthalpy of fusion.
3-Methoxybenzoic acid ͓C 8 H 8 O 3 ; 586-38-9͔. The handbook melting point is 110.5°C, but the chosen value was taken from a phase diagram study. 57 The enthalpy of fusion is not known experimentally, and so it was estimated ͑next section͒.
Nicotinamide ͓C 6 H 6 N 2 O; 98-92-0; 3-Pyridinecarboxamide; Niacinamide͔. Handbooks indicate a melting range of 128-131°C. The chosen value 5, 35, 67, 68 is close to 129°C. The enthalpy of fusion was reported 32 22.8 or 14 23.6 kJ mol Ϫ1 . A value 68 of 26.1 J mol Ϫ1 is probably a misprint.
Nicotinic acid ͓C 6 H 5 NO 2 ; 59-67-6; 3-Pyridinecarboxylic acid͔. The melting range from handbooks is 236-237°C; the chosen value was adopted from a phase diagram study. 67 The enthalpy of fusion, being unknown, was estimated ͑next section͒. 30 melting range is 112-114°C. The enthalpy of fusion 30, 40, 70, 71 lies in the range 17.3-30.1 kJ mol Ϫ1 .
Paracetamol ͓C 8 H 9 NO 2 ; 103-90-2; Acetamide, N-͑4-hydroxyphenyl͒-; Acetaminophen͔. Handbook data for the melting point indicate 167-171°C. The adopted value is from careful studies on the pure substance. 35, 62, 72 There is one datum for the enthalpy of fusion. 14 Phenacetin ͓C 10 H 13 NO 2 ; 62-44-2: Acetamide, N-͑4-ethoxyphenyl͒-͔. Handbook data for the melting point are 134-138°C. The lower limit is probably correct. [35] [36] [37] 62, 73 The enthalpy of fusion is 32,74,75 21.8-34.7 kJ mol Ϫ1 .
Phenazone ͓C 11 H 12 N 2 O; 60-80-0; 3H-Pyrazol-3-one, 1,2dihydro-1,5-dimethyl-2-phenyl-; Antipyrine͔. According to handbooks, the melting range is 111-114°C. A lower temperature was adopted. 35, 42, 46 The enthalpy of fusion is the mean of two experimental values. 32, 45 Phenobarbital ͓C 12 H 12 N 2 O 3 ; 50-06-6; 2,4,6͑1H,3H,5H͒-Pyrimidinetrione, 5-ethyl-5-phenyl-; Luminal͔. The melting range is given as 174-178°C in handbooks. The is one value 38 for their enthalpy of fusion.
Phenylbutazone ͓C 1920 N 2 O 2 ; 50-33-9; 3,5-Pyrazolidinedione, 4-butyl-1,2-diphenyl-; Butadione͔. The handbook melting range is 105-107°C. A low value is indicated. [76] [77] [78] The enthalpy of fusion lies in the range 32, 44, 77, 78 
Quinine ͓C 20 H 24 N 2 O 2 ; 130-95-0; Cinchonan-9-ol, 6Ј-methoxy-, ͑8␣,9R͒-͔. The melting range is 176-177°C ͑with some decomposition͒, according to handbooks. There is no experimental value for the enthalpy of fusion, and so it was estimated ͑next section͒.
Succinimide ͓C 4 H 5 NO 2 ; 123-56-8; 2,5-Pyrrolidinedione͔. The handbook data for melting indicate 125-127°C, but a lower value was adopted on the basis of more careful work on the pure substance. 79, 80 There is no experimental value for the enthalpy of fusion, and so it was estimated ͑next section͒.
Sulfacetamide ͓C 8 H 10 N 2 O 3 S; 144-80-9; Acetamide, N-͓͑4-aminophenyl͒sulfonyl͔-͔. Handbook melting point data indicate 181-184°C, and the higher temperature was adopted. 81, 82 There is one value 81 for the enthalpy of fusion.
Sulfadiazine ͓C 10 H 10 N 4 O 2 S; 68-35-9; Benzenesulfonamide, 4-amino-N-2-pyrimidinyl-͔. The melting range according to handbooks is 252-262°C. A value close to 258°C was adopted. 10, 75, 83 The reported enthalpy of fusion 10,75,81,83,84 is 31.2-43.7 kJ mol Ϫ1 .
Sulfamerazine ͓C 11 H 12 N 4 O 2 S; 127-79-7; Benzenesulfonamide, 4-amino-N-͑4-methyl-2-pyrimidinyl͒-͔. The handbook melting range range is 234-238°C, with some decomposition. A value near 236°C was adopted. 81, 85 The enthalpy of fusion 75,81,84,85 is 31.6-45.8 kJ mol Ϫ1 .
Sulfamethoxazole ͓C 10 H 11 N 3 O 3 S; 723-46-6; Benzenesulfonamide, 4-amino-N-͑5-methyl-3-isoxazolyl͒-͔. The melting range according to handbooks is 167-173°C. The chosen value 10,83,86 is near 170°C. The enthalpy of fusion is 84 28.7 or 10,86 32.2 kJ mol Ϫ1 .
Sulfamethoxypyridazine ͓C 11 H 12 N 4 O 3 S; 80-35-3; Benzenesulfonamide, 4-amino-N-͑6-methoxy-3-pyridazinyl͒-͔.
JAMES SANGSTER
Handbook data for the melting point indicate 180-183°C, and a value near the lower is probably accurate. 10, 81, 83, 87 The enthalpy of fusion 10, 81, 83, 87, 88 lies in the range 29.0-32.6 kJ mol Ϫ1 . Sulfanilamide ͓C 6 H 8 N 2 O 2 S; 63-74-1; Benzenesulfonamide, 4-amino-͔. The handbook data indicate 164-167°C as the melting range, and 165°C was adopted. 76, 82 Since there is no experimental value for the enthalpy of fusion, it was estimated ͑next section͒.
Sulfapyridine ͓C 11 H 11 N 3 O 2 S; 144-83-2; Benzenesulfonamide, 4-amino-N-2-pyridinyl-͔. The handbook melting range is 191-193°C. The adopted value 35, 64 is close to 191°C. The enthalpy of fusion is the mean of two measurements. 32, 81 Sulfathiazole ͓C 9 H 9 N 3 O 2 S 2 ; 72-14-0; Benzenesulfonamide, 4-amino-N-2-thiazolyl-͔. The melting range according to handbooks is 200-204°C. A value close to the lower limit was adopted. 23, 75, 76, 84 The enthalpy of fusion lies in the range 23,75,84 24.1-28.9 kJ mol Ϫ1 .
Sulfisoxazole
Handbook data indicate 194-198°C for the melting range. The adopted value was taken from experimental results. 81, 84 The enthalpy of fusion is the mean of two measurements. 81, 84 Theophylline
The melting range is 268-274°C according to handbooks. The adopted value 41, 72 is the upper limit. There is one datum 41 for the enthalpy of fusion.
Thiourea ͓CH 4 N 2 S; 62-56-6͔. The handbook data indicate 175-182°C as the melting range. An otherwise reliable compilation 40 states 172.4°C. The adopted value was taken from a phase diagram measurement. 43 There is one datum 40 for the enthalpy of fusion.
Trimethoprim ͓C 14 H 18 N 4 O 3 ; 738-70-5; 2,4-Pyrimidinediamine, 5-͓͑3,4,5-trimethoxyphenyl͒methyl͔-͔. Handbook data for the melting point are 199-203°C. The adopted value is close to the lower limit. 10, 83, 86 There is one value for the enthalpy of fusion. 10 Urea ͓CH 4 N 2 O; 57-13-6͔. The handbook melting point is 132.6°C, while a survey of phase diagram measurements gave a range of 130-134°C, perhaps with some decomposition. 89 The enthalpy of fusion found experimentally 30,90-93 lies in the range 13.0-15.5 kJ mol Ϫ1 .
It should be mentioned that no claim is made concerning the ultimate accuracy of the data in Table 1 . The aim was to obtain reasonably accurate data for the purpose of calculating phase diagrams.
Estimation of Enthalpy of Fusion
For some compounds in Table 1 , experimental enthalpies of fusion were unavailable and so they were estimated by one of several methods, described here.
For chemically simpler molecules, a group-contribution method 94 is useful. The enthalpy of fusion of aspirin was estimated by this method.
In Sec. 4, Eq. ͑1͒ relates the limiting liquidus slope in a phase diagram to the enthalpy of fusion of a pure component. Thus a phase diagram can be a source of experimental data for the enthalpy of fusion. In choosing phase diagram data for this purpose, attention was paid to the overall quality of the phase diagram data and to the possibility that the initial slope was obscured by deviations caused by large nonidealities of the liquid phase. The enthalpies of fusion of the following substances were found in this way ͑the reference indicates the source of the phase diagram data͒: succinimide, 80 nicotinic acid, 95, 96 sulfanilamide, 97 quinine 98 and chlormadinone acetate. 54 It is a commonly observed fact that the entropies of fusion of chemically and structurally similar organic compounds are also similar. This approximation was exploited in the estimation of the enthalpy of fusion of three substances. Thus, for isonicotinamide, the experimental entropy of fusion of the 3-isomer ͑nicotinamide͒ is 57.64 J mol Ϫ1 K Ϫ1 . Using the relation ⌬ fus HϭT fus ⌬ fus S, one obtains (430.4)(57.64) ϭ24.8 kJ mol Ϫ1 . For 3-methoxybenzoic acid, the entropy of fusion of the 4-isomer 40 is 62.04 J mol Ϫ1 K Ϫ1 , where the required datum is 23.8 kJ mol Ϫ1 . For etofylline, the available entropy of fusion 99 was that for 8-ethyltheophylline, 68.23 J mol Ϫ1 K Ϫ1 , where the required datum is 29.6 kJ mol Ϫ1 .
The uncertainty in these estimated data is about Ϯ20%. This is greater than experimental error in, for example, DSC measurements. The effect of this uncertainty in the calculation of phase diagrams ͑Figs. 1-60͒ is to add incrementally to the uncertainty in deduced excess Gibbs energy of the liquid and thermodynamic properties of intermediate compounds. The main features of the diagram are not affected. In the binary systems sulfanilamide-benzocaine, sulfanilamide-4-aminobenzoic acid and chlormadinone acetate-ethinyl estradiol, the enthalpy of fusion of one component was derived from the phase diagram under thermodynamic analysis. In these cases there is a slight circularity in the thermodynamic argument, which, however, had little practical effect.
Temperature Dependence of Enthalpy of Fusion
In the present work, phase diagrams are calculated on the assumption that the enthalpies of fusion of pure components are independent of temperature. This is equivalent to assuming that the heat capacities of solid and liquid are the same at all temperatures. This is, of course, not strictly true. The magnitude of the error in consequence of this assumption may be seen from a specific example. The heat capacities of liquid and solid benzocaine have been measured near the melting point. 50 At the melting point, the given data are 50
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where T is in Kelvin. In Eqs. ͑5͒-͑8͒ it has been assumed that the heat capacity curve of a phase beyond its normal range of existence is parallel to that of the other phase. 50 The enthalpy and entropy of fusion at different temperatures can be calculated from thermodynamic first principles, using the given data of Eqs. ͑2͒-͑8͒. The behavior is summarized in Table 2 , which shows that both enthalpy and entropy of fusion vary with temperature in a well-behaved fashion. The practical consequence of assuming temperature independence will manifest itself as an incremental error in the derived excess Gibbs energy of the liquid and thermodynamic properties of intermediate compounds. The main features of the phase diagram will remain unaffected.
Thermodynamic Analysis and Presentation of Results
For each binary system, the source and identity of the data are indicated, together with any stated information on eutec-tic, peritectic or transition points. If there are intermediate compounds, stoichiometry, enthalpy of fusion, melting points or other information are mentioned, according to sources. The reported phase diagram data points are included in the calculated phase diagram; metastable transitions, if any, are mentioned but do not appear on the diagram. The general aspect of the phase diagram is noted, along with an overall assessment of data quality ͑scatter, adherence to thermodynamic constraints, etc.͒. Preliminary calculations and assumptions made prior to optimization, if any, are stated. The results of the calculation, in addition to the phase diagram, are given as calculated eutectic and peritectic temperatures and compositions, or melting points of congruent compounds. Calculated thermodynamic data are also presented: these include the Gibbs energy of fusion and of formation ͑from the pure liquids͒ of any intermediate compounds, as well as the excess Gibbs energy of the liquid. These quantities are designated ⌬ fus G o , ⌬ f G o and G E (l), respectively. When the given data are sparse or contradictory, the probable nature of the phase diagram is discussed in the light of general thermodynamic principles and behavior of similar systems. Finally, an estimate of the uncertainty in the calculated diagram is made, indicating the degree of confidence appropriate to the calculations in each case.
Where there are more than one eutectic in a system, they may be referred to as E 1 , E 2 , etc., in the discussion for individual systems; peritectics are indicated by P.
In the present article, no far-reaching claims are made concerning the ultimate correctness of the calculated phase dia- 
Analysis of Phase Diagrams

Phenazone "A…؉Phenylbutazone "B…
Data were obtained by DTA. 100 No eutectic information was stated. In the optimization, the eutectic data were preferentially weighted, as the liquidus data by themselves entailed a higher eutectic temperature than that observed. The phase diagram, Fig. 1 , was calculated with the use of Eq. ͑9͒
and the calculated eutectic is 82.5°C, x B ϭ0.550. An uncertainty of Ϯ4°may be assigned to the diagram.
Phenazone "A…؉Phenacetin "B…
Data were obtained by DTA 100 and the thaw-melt method. 98 The reported eutectic 98 is 75°C, x B ϭ0.412, but the eutectic data from DTA 100 lie higher than 75°C. In a preliminary optimization, it was ascertained that the liquidus data are consistent with the observed 98 eutectic temperature and that the thaw-melt data 98 were of better quality. The phase diagram, Fig. 2 , was calculated with the use of Eq. ͑10͒:
and the calculated eutectic is 74.0°C, x B ϭ0.420. An uncertainty of Ϯ2°may be assigned to the calculated diagram. 
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Phenazone "A…؉Urea "B…
Data were obtained by the thaw-melt method. 98 The reported eutectic is 87°C, x B ϭ0.533. All the liquidus data were optimized to give
and the calculated phase diagram is given in Fig. 3 . The calculated eutectic is 89.1°C, x B ϭ0.500. An uncertainty of Ϯ2°may be assigned to the calculated diagram.
Paracetamol "A…؉Phenazone "B…
Data for the phase diagram were obtained by DTA using fused and physical mixtures. 8 Only the data from fused mixtures are considered here and are shown in the calculated phase diagram. These data consisted of a number of thermo-gram traces and a phase diagram with smoothed phase boundaries ͑no data points͒. The reported eutectic 8 is 83°C, x B ϭ0.76; the existence of a 1:1 congruently melting compound melting at 107°C was considered possible. For the calculated phase diagram, the thermogram data were converted to liquidus, eutectic and peritectic data points and are shown on the phase diagram. An optimization was performed under the assumption of a eutectic temperature of 83°C and the existence of a 1:1 compound. The phase diagram, Fig. 4 , was calculated with the use of Eq. ͑12͒
and the thermodynamic properties of the compound AB/2 are 
Sulfadiazine "A…؉Trimethoprim "B…
Data were obtained by DSC 83 ͑the same data also appear in another publication 10 ͒. The reported eutectic 10,83 is 189.5°C, x B ϭ0.75, although the plotted data 10, 83 show a eutectic temperature of 185.6°C. The phase diagram, Fig. 5 , was calculated with the use of Eq. ͑15͒
and the calculated eutectic is 185.7°C, x B ϭ0.737. An uncertainty of Ϯ2°may be assigned to the calculated diagram.
Sulfamethoxazole "A…؉Trimethoprim "B…
Phase diagram data were obtained by DSC. 86 The reported eutectics are 157.3°C, x B ϭ0.17 and 177.9°C, x B ϭ0.61. 
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for the liquid, and for the compound AB/2
The calculated eutectics are 157.3°C, x B ϭ0.199 and 177.9°C, x B ϭ0.604. The compound melts at 180.2°C; the calculated phase diagram is shown in Fig. 6 . Some of the experimental liquidus data lie too high for thermodynamic consistency. An uncertainty of Ϯ1°may be assigned to the calculated diagram.
Benzoic Acid "A…؉Trimethoprim "B…
Phase diagram data were obtained by DSC. 51 The reported eutectics are E 1 ϭ106.8°C, x B ϭ0.14; E 2 ϭ132.5°C, x B ϭ0.37; E 3 ϭ145.0°C, x B ϭ0.52. There are two intermediate compounds, 2:1 and 1:1 melting congruently at 134.2 and 145.9°C, respectively. The 1:1 compound was prepared by mixing stoichiometric amounts of components in water or methanol or ethyl acetate. The 2:1 compound was also synthesized in the same way in water or diethyleneglycol solution. The 2:1 compound also has a metastable melting point of 126.5°C. The enthalpies of fusion of the compounds were measured as 52.3 and 56.1 kJ mol Ϫ1 , respectively. X-ray and IR spectra were obtained for both compounds. The 1:1 compound is monoclinic, aϭ1.1295 nm, bϭ2.8266 nm, c ϭ0.6543 nm, ␤ϭ100.97°, space group P2 1 /N, Zϭ4. The stable form of the 2:1 compound is triclinic, aϭ1.4595 nm, bϭ1.0195 nm, cϭ0.9455 nm, ␣ϭ89.67°, ␤ϭ97.37°, ␥ ϭ104.6°, space group P 1 or P T , Zϭ2. A thermal event, observed at 120.2°C, was possibly a metastable eutectic between the 2:1 compound and trimethoprim. 51 All liquidus data were optimized, with the result
for the liquid. For the compound AB/2,
and for A 2 B/3
The calculated eutectics ͑Fig. 10 from equimolar mixtures in 95% ethanol, methanol or water. X-ray and IR spectra were also taken. 10 All liquidus data were optimized, and the experimental eutectic temperatures were weighted preferentially. For the liquid, the result is
and for the compound AB/2
The calculated phase diagram is shown in Fig. 8 . The calcu- 
Aminophenazone "A…؉4-Aminophenazone "B…
Phase diagram data were obtained by DSC, DTA and the microthermal methods. 46 The reported eutectic is 79°C, x B ϭ0.50. The eutectic mixture was examined by photomicroscopy. The liquidus data from the three methods are in very good agreement, and not all are shown on the phase diagram. From the optimization, the result is
and the calculated phase diagram appears in Fig. 9 . The li-quidus data are consistent with a slightly lower calculated eutectic, 78.0°C, x B ϭ0.500. An uncertainty of Ϯ2°may be assigned to the phase diagram.
Aminophenazone "A…؉Phenacetin "B…
Data were obtained by DTA 100 and no eutectic data were stated. All liquidus data were optimized, with preferential weighting for the observed eutectic temperature. For the liquid,
and the calculated phase diagram is shown in Fig. 10 . The calculated eutectic is 82.0°C, x B ϭ0.320. An uncertainty of Ϯ3°may be assigned to the calculated diagram. 
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Aminophenazone "A…؉Phenylbutazone "B…
Data were obtained by DTA, 100 and no eutectic data were stated. There is scatter in the observed eutectic arrests. All the liquidus data were optimized, with preferential weighting of a eutectic temperature given by data near the eutectic composition. For the liquid,
and the calculated phase diagram is shown in Fig. 11 . The calculated eutectic is 80.8°C, x B ϭ0.500. An uncertainty of Ϯ4°may be assigned to the calculated diagram.
Aminophenazone "A…؉Phenazone "B…
Liquidus data were obtained by DSC 46 , DTA 46,100 and hotstage microscopy. 46 Data obtained by the three methods were in good agreement. The observed eutectic 46 is 81.2°C, x B ϭ0.48. The eutectic mixture was examined by photomicroscopy. 46 In the optimization, all liquidus data were weighted equally, and the result is
The calculated phase diagram is shown in Fig. 12 , with a calculated eutectic of 81.6°C, x B ϭ0.463. It is apparent that the older data 46 are of better quality than the other. An uncertainty of Ϯ1°may be assigned to the calculated diagram.
Thiourea "A… and Aminophenazone "B…
Data were obtained by DSC and light transmission 43 and are in good agreement. The reported eutectic is 92°C, x B ϭ0.73 and peritectic 138°C, x B ϭ0. 27 . From x-ray diffraction spectra, the stoichiometry of the compound was found to be 3:1. Optimization of liquidus data resulted in Eq. ͑31͒ 
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͑31͒
For the liquid, and for the compound A 3 B/4
The calculated diagram appears in Fig. 13 and the calculated invariant points are Eϭ93.0°C, x B ϭ0.310.
The experimental data are well reproduced and an uncertainty of Ϯ1°may be assigned to the calculated diagram.
Urea "A…؉Aminophenazone "B…
Data were obtained by DSC and light transmission 43 and are in good agreement. The reported eutectics are E 1 ϭ125°C, x B ϭ0.21 and E 2 ϭ97.5°C, x B ϭ0.80. A 3:1 compound melts congruently at 125°C. The limiting liquidus slope at the left hand side ͑LHS͒ definitely suggests some solid solubility there, although none was mentioned by the investigators. 43 Some liquidus data at x B Ͼ0.5 proved to be grossly inaccurate. The E 1 and compound melting temperatures were evidently very close. In these circumstances, it was decided to construct a phase diagram using Eq. ͑34͒
and a solid solution with properties such that the calculated E 1 temperature would be near the observed datum. The thermodynamic properties of the compounds could not be obtained from optimization, and hence reasonable values were assigned for A 3 B/4: 
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⌬ f G o ϭϪ28 000ϩ65.3248T J mol Ϫ1 .
͑36͒
The solid solution based on urea was represented by a Henrian activity coefficient independent of temperature given by
The calculated phase diagram is given in Fig. 14, and 
Aminophenazone "A…؉Allobarbital "B…
Data were obtained by the thaw-melt method from physical and fused mixtures 57 ͑only data from fused mixtures are shown in the phase diagram͒. No invariant points were stated, but the presence of an incongruently melting 1:1 com-pound was postulated. The compound was synthesized from stoichiometric quantities of components in water solution. There was a metastable eutectic 57 at about 80°C. All liquidus data were used in the optimization, with preferential weighting for observed eutectic and peritectic temperatures. For the liquid, the result was
The calculated phase diagram is shown in Fig. 15 . The cal- 
Aminophenazone "A…؉Barbital "B…
Data were obtained by the thaw-melt method with both fused and solvent-evaporated mixtures. 5 The results from the two series are in good agreement. No invariant points were stated, but a metastable eutectic at about 88°C was observed. A 1:1 compound, which was synthesized from equimolar amounts of components in water solution, melted incongruently. All liquidus data were optimized, with the result
for the liquid and
for the compound AB/2. The calculated phase diagram appears in Fig. 16, and 
Aminophenazone "A…؉Sulfisoxazole "B…
Data were obtained by the thaw-melt method on both used and solvent-evaporated mixtures. 5 The data from the two series are in good agreement. No invariant points were stated by the authors, but a metastable eutectic at about 82°C was mentioned. The 1:1 compound was synthesized from equimolar amounts of components in water solution; DTA on this compound indicated an incongruent melting point of 115.6°C. An optimization was performed on all the liquidus data, with the results
for the compound AB/2. The calculated phase diagram is shown in Fig. 17 
3-Methoxybenzoic Acid "A…؉Etofylline "B…
Data were obtained by the thaw-melt method 57 with both physical and fused mixtures ͑only the results for fused mixtures are shown on the diagram͒. No invariant points were stated, but a metastable eutectic at about 85°C was observed. A 1:1 compound melts incongruently. All liquidus data were optimized, with the results
for the compound AB/2. The calculated phase diagram is shown in Fig. 18, and 
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Benzoic Acid "A…؉Etofylline "B…
Data were obtained by the thaw-melt method 57 on physical, fused and solvent-evaporated mixtures ͑only results from fused and solvent-evaporated mixtures are shown on the phase diagram͒. A metastable eutectic at about 94°C was observed, but no other invariant point information was given. A 1:1 compound melts incongruently. All liquidus data were optimized. For the liquid,
were derived. The calculated phase diagram appears in Fig.  19 
Aminophenazone "A…؉Etofylline "B…
Data were obtained by the thaw-melt method 57 on both physical and fused mixtures ͑only fused mixture data are shown on the phase diagram͒. A metastable eutectic of 101°C was reported, but no other information was offered. The liquidus data could be fit very well by an expression
and the calculated phase diagram is shown in Fig. 20 . The liquidus data entail a eutectic 101.8°C, x B ϭ0.142; this temperature is significantly above the experimental datum 
4-Nitroaniline "A…؉Etofylline "B…
Data were obtained with the thaw-melt method 57 on physical and fused mixtures ͑only data from fused mixtures are shown in the phase diagram͒. No invariant points were reported, but a metastable eutectic at 111°C was observed, as well as the existence of an incongruently melting 1:1 compound. In a preliminary calculation, it was ascertained that the liquidus data entail eutectic and peritectic temperatures consistently higher than those observed. For constructing the phase diagram, therefore, these temperatures were preferen-tially weighted and thermodynamic properties of the compound were assigned to reproduce the experimental data as closely as possible. For the liquid,
The calculated phase diagram is shown in Fig. 21 
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Benzidine "A…؉Etofylline "B…
Data were obtained by the thaw-melt method 57 on physical and fused mixtures ͑only the fused mixture data are shown on the phase diagram͒. A metastable eutectic at about 98°C and an incongruently melting 1:1 compound were reported, but no other information. All liquidus data were optimized with the results
for the compound AB/2. The calculated phase diagram is shown in Fig. 22 , with Eϭ101.6°C, x B ϭ0.326 and P ϭ105.4°C, x B ϭ0.395. An uncertainty of Ϯ2°may be assigned to the calculated diagram.
Hydroquinone "A…؉Etofylline "B…
Data were obtained by the thaw-melt method 57 on both physical and fused mixtures ͑only data from fused mixtures are shown in the phase diagram͒. Although no invariant point data were stated, metastable eutectics at about 121°C and 113°C and the presence of a congruently melting 3:2 compound were mentioned. The liquidus data from physical mixtures coincided with those from fused mixtures ͑other temperature arrests did not͒. The liquidus data themselves entailed eutectic temperatures higher than those observed, and so in the optimization greater weight was given to these temperatures. For the liquid, 
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G E ͑ l ͒ϭx A x B ͑ Ϫ18 000ϩ11 248x B ͒ J mol Ϫ1 ,
͑60͒
and for the compound A 3 B 2 /5
The calculated phase diagram is shown in Fig. 23 
4-Nitrophenol "A…؉Etofylline "B…
Data were obtained by the thaw-melt method 57 on physical and fused mixtures ͑only data from fused mixtures are shown in the diagram͒. Although no invariant point data were stated, a metastable eutectic at about 57°C and the existence of a 2:1 congruently melting compound were noted. All liquidus data were optimized, and the calculated phase diagram ͑Fig. 24͒ was constructed with the quantities 
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Phenacetin "A…؉Urea "B…
Data were obtained by the thaw-melt method. 98 Liquidus and monotectic data were tabulated, but data defining the liquid miscibility gap were available only as points on a phase diagram. The eutectic was reported to be 129.0°C, x B ϭ0.305, and the liquid miscibility gap lay in the range 0.342Ͻx B Ͻ0.963. The consolute point, read off the phase diagram, was ϳ164°C, x B ϳ0.78. It was found that a consolute temperature as low as that experimentally suggested 98 was inconsistent with the remaining ͑better established͒ diagram. The experimental monotectic temperature (128.7°C) was well reproduced by the quantity
and the extent of the miscibility gap, Fig. 25 , was 0.284 рx B р0.946. The calculated eutectic is 123.7°C, x B ϭ0.252. The calculated two-liquid envelope is suggestive only. An uncertainty of Ϯ2°may be assigned to the remainder of the diagram.
Acetanilide "A…؉Phenacetin "B…
Data were obtained by DSC. 36 Complete solid solution was reported, with a minimum temperature of 80°C, x B ϭ0.337. It was found, in preliminary calculations, that all the observed liquidus data were consistent with zero solid solubility and the quantity
for the liquid. The reason for the thermal event͑s͒ at ϳ82°C is therefore puzzling. A congruently melting compound in the middle of the diagram could conceivably account for two eutectic temperatures near 82°C; its stoichiometry, however, could not be 1:1. The presence of an incongruently melting An alternative construction is possible. The reported 36 lowest temperature arrests at ϳ82°C could be construed as indicating a eutectic temperature; the reported 36 ''minimum'' composition, its composition. In this case, the calculated phase diagram would be that in Fig. 26͑b͒ and the liquid would be described by
Without further information, a more definitive construction cannot be made.
Phenacetin "A…؉Phenobarbital "B…
Data were obtained by DTA 4 and the reported eutectic is 114°C, x B ϭ0.33. All liquidus data were optimized, with the result
and the calculated phase diagram is shown in Fig. 27 . The calculated eutectic is 114.6°C, x B ϭ0.340. An uncertainty of Ϯ2°may be assigned to the calculated diagram. 
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range 0.15Ͻx B Ͻ0.55 were ascribed tentatively 4 to a metastable form of phenobarbital. The liquidus data, upon optimization, proved to be thermodynamically consistent with a eutectic temperature below that observed:
as shown in the calculated phase diagram ͑Fig. 28͒; calculated eutectic: 140.0°C, x B ϭ0.450. An uncertainty of Ϯ1°m ay be assigned to the calculated diagram.
Urea "A…؉Phenobarbital "B…
Data were obtained by DTA 12, 102 and thermal analysis ͑cooling curves͒. 103 Both physical mixtures 102 12, 102 suggested the presence of a solid solution based on phenobarbital; refractive index, photomicrographic analysis and dissolution rate studies 12 also suggested the presence of a solid solution. The limits of the solid solution were given 12 as 0.51Ͻx B Ͻ1 at the eutectic temperature. On the contrary, the phase diagram data and photomicrographic analysis by other investigators 103 claimed no solid solution.
In addition, the existence of an incongruently melting 1:2 compound was postulated. 102 Both the data and their interpretation are confused. The phase diagram data themselves are of poor quality. In preliminary calculations, it was ascertained that the high eutectic temperature and lack of eutectic arrests beyond x B ϭ0.6 were consistent with a solid solution based on phenobarbital; 
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there is no justification for the presence of compounds. For construction of the phase diagram, Eq. ͑70͒ was assumed
and the solid solution was assumed to be Henrian; the Henrian activity coefficient
independent of temperature was chosen in order to place the eutectic temperature near the observed data points. The calculated phase diagram is shown in Fig. 29 , and the calculated eutectic is 110.6°C, x B ϭ0.216. The solid solution extends to x B ϭ0.756 at the eutectic temperature. The diagram is suggestive only.
Theophylline "A…؉Phenobarbital "B…
Data were obtained by DTA 4 and the microthermal method 104 ͑smooth line diagram, no data points͒. The reported eutectics 4 are E 1 ϭ248°C, x B ϭ0.25 and E 2 ϭ169°C, x B ϭ0.96. There is a 2:1 compound melting congruently at 4 252°C. The x-ray diffraction spectra of mixtures 4 at x B ϭ0.33 and 0.4 support the existence of a compound. The 2:1 compound was synthesized from alcohol solution 105 with a melting point of 250.7-251.7°C. Another report 104 indicates the existence of 1:1 and 2:1 compounds melting at 254 and 244°C, respectively. Some thermal events in the range 4 159-164°C were thought to be due to metastable transitions of phenobarbital.
A preliminary calculation showed that liquidus data 4 at x B Ͼ0.6 were inaccurate and no compound was thermodynamically stable. The phase diagram, Fig. 30 , was calculated with the use of Eq. ͑72͒
for the liquid and, for the compound A 2 B/2,
Other calculated data are: E 1 ϭ247.1°C, x B ϭ0.232 and E 2 ϭ168.5°C, x B ϭ0.898. The compound melts at 250.3°C. An uncertainty of Ϯ4°may be assigned to the calculated diagram.
Quinine "A…؉Phenobarbital "B…
Data were obtained from DTA measurements on both physical and fused mixtures. 4 The reported eutectics 4 ͑fused mixtures͒ are E 1 ϭ164°C, x B ϭ0.2 and E 2 ϭ158°C, x B ϭ0.8. A 1:1 compound melts congruently at 185°C. The liquidus data from the physical and fused mixtures agree quite well; the two preparative methods give different eutectic temperatures, however. There is a metastable eutectic in the range 120-130°C. X-ray diffraction spectra 4 on the powder confirmed the existence of the 1:1 compound. The compound was also synthesized from alcohol solution 7, 106 and melted at 106 182-183°C or 7 184-185°C. The eutectic arrests 4 were scattered, and preliminary calculations showed that both eutectic temperatures from fused mixtures could not be reproduced simultaneously. In this case, it was decided to place more weight on the liquidus data; the optimization yielded
for the compound AB/2. Calculated data from the phase diagram, Fig. 31 
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Caffeine "A…؉Phenobarbital "B…
Data were obtained by thermal analysis, DTA and the thaw-melt method. 4 The 1:1 compound is described as 4 ''incongruently melting'' but reference is made exclusively to two ''eutectic'' temperatures ͑the higher should be called ''peritectic''͒. Thermal events between 120 and 130°C were ascribed 4 to metastable eutectics. The eutectic 4 is 135 ͑or 138͒°C, x B ϭ0.67 and the peritectic temperature is 140, 141 or 143°C. A 1:2 compound was prepared 107 from aqueous solution ͑melting point 145-146°C) as well as a 1:1 compound ͑not isolated͒. Liquidus data from all three methods agree well on the LHS, and, on the RHS, the DTA and thaw-melt data are concordant; in the central region there is much scatter. All liquidus data in the intervals 0Ͻx B Ͻ0.5 and 0.7Ͻx B Ͻ1 were optimized, with the result
for the compound AB/2. The phase diagram, calculated with the use of Eqs. ͑78͒ and ͑80͒, is shown in Fig. 32 
͑81͒ and the calculated phase diagram, Fig. 33 , shows a eutectic 121.5°C, x B ϭ0.327. An uncertainty of Ϯ1°may be assigned to the diagram.
Sulfanilamide "A…؉Phenylbutazone "B…
Data were obtained by DSC and light transmission. 76 The reported eutectic is 99°C, x B ϭ0.91. X-ray diffractograms of mixtures corresponded to the two components only. The liquidus data by themselves entail a eutectic temperature somewhat higher than that observed. Weighting the eutectic temperature preferentially, the optimization yielded
and the calculated phase diagram, Fig. 34 
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⌬ f G o ϭϪ24 400ϩ51.7615T J mol Ϫ1
͑85͒
for the compound AB/2. The calculated phase diagram is shown in Fig. 35 , and other calculated data are E 1 ϭ141.7°C, x B ϭ0.229 and E 2 ϭ146.0°C, x B ϭ0.714. The compound melts at 151.9°C. A few liquidus data points are seen to be inconsistent with the rest of the diagram. An uncertainty of Ϯ1°may be assigned to the calculated diagram.
Sulfanilamide "A…؉Benzocaine "B…
Data were obtained by the thaw-melt method. 97 The reported eutectic is 82.5°C, x B ϭ0.87. The phase diagram, Fig.  36 , was calculated with the aid of
and shows a eutectic of 82.5°C, x B ϭ0.867. An uncertainty of Ϯ1°may be assigned to the calculated diagram.
12.37.
Sulfanilamide "A…؉4-Aminobenzoic Acid "B… Data were obtained by the thaw-melt method 97 and the reported eutectic is 138.5°C, x B ϭ0.38. The phase diagram, Fig. 37 , was calculated with the use of Eq. ͑87͒
and shows a eutectic 138.6°C, x B ϭ0.404. Two liquidus data near x B ϭ0.4 are seen to be inconsistent with the remaining data. An uncertainty of Ϯ1°may be assigned to the calculated diagram. 108 The reported eutectic is 165°C, x B ϭ0.6. X-ray diffraction of mixtures confirmed the fact that the system is a simple eutectic. ͑A stability constant for an associated species in aqueous solution was derived from solubility measurements 107 at 30°C.) All liquidus data were optimized to give Eq. ͑88͒
with which the phase diagram, Fig. 38 , was calculated. The calculated eutectic is 165.1°C, x B ϭ0.601. An uncertainty of Ϯ1°may be assigned to the calculated diagram.
Sulfathiazole "A…؉Phenylbutazone "B…
Data were obtained by DSC and light transmission. 76 The reported eutectic is 103°C, x B ϭ0.98 and peritectic 160°C, x B ϭ0.49. X-ray diffraction data on the 2:1 compound at room temperature were indexed according to triclinic symmetry, with aϭ1.0403 nm, bϭ1.0673 nm, cϭ1.9628 nm, ␣ϭ82.21°, ␤ϭ99.98°, ␥ϭ102.36°, Zϭ2. The compound undergoes a transition at 150°C, and unindexed diffraction data were obtained for the high temperature form. A metastable eutectic was observed at 94°C. All liquidus data were optimized, with the results 
Phenazone "A…؉Sulfathiazole "B…
Data were obtained by DSC and light transmission. 108 The reported eutectics are E 1 ϭ99°C, x B ϭ0.17 and E 2 ϭ133°C, x B ϭ0.53. The 1:1 compound melts congruently at 135°C. X-ray diffraction data on the compound were indexed according to monoclinic symmetry: aϭ1.2669 nm, b ϭ1.2590 nm, cϭ1.3941 nm, ␤ϭ105.18°, Zϭ4, space group P2 1 /c. All liquidus data were optimized with the result
for the compound AB/2. The calculated phase diagram is shown in Fig. 40 97 and the reported eutectic is 86°C, x B ϭ0. 96 . In a preliminary calculation, it was ascertained that the liquidus data were consistent with a eutectic temperature slightly above that observed. The phase diagram, Fig. 41 , was calculated with the use of Eq. ͑95͒
and shows a calculated eutectic of 86.6°C, x B ϭ0.936. An uncertainty of Ϯ2°may be assigned to the calculated diagram.
Sulfathiazole "A…؉4-Aminobenzoic Acid "B…
Data were obtained by the thaw-melt method 97 and the reported eutectic is 150°C, x B ϭ0.57. All data were optimized to give the expression
and the calculated phase diagram appears in Fig. 42 
represented the liquid and
the compound A 2 B/3. The calculated phase diagram appears in Fig. 43 
Nicotinamide "A…؉Indomethacin "B…
Data were obtained by hot-stage microscopy. 11 Samples were prepared from fused mixtures and two ͑of 5 and 10 wt %͒ from solvent-evaporated mixtures. A metastable eutectic at 83°C and a stable one at 107°C were reported. A solid solution based on nicotinamide was postulated, together with two incongruently melting compounds ͑1:1 and 1:2͒. IR 
920
JAMES SANGSTER spectra of mixtures and UV spectra of aqueous mixtures were claimed to yield results confirming the existence of complexes, as did solubility studies. The liquidus data are sparse and of poor quality. Preliminary calculations showed that a solid solution based on nicotinamide was not needed. For construction of a phase diagram a eutectic temperature near 107°C was assumed. A 1:1 compound proved to be possible thermodynamically, but stable only in a narrow temperature range. For the liquid, Eq. ͑100͒ was used
The calculated phase diagram appears in Fig. 44 
Nicotinamide "A…؉Sulfamerazine "B…
Data were obtained by the thaw-melt method. 5 Physical, fused and solvent-evaporated mixtures were used. Only data from fused mixtures are shown in the diagram. No invariant points were stated, but a metastable eutectic at 123°C was reported and also the presence of an incongruently melting 
for the compound A 3 B 2 /5. The calculated phased diagram is shown in Fig. 45 
and the phase diagram calculated with this quantity is shown in Fig. 46 . The calculated eutectic is 138.2°C, x B ϭ0.296. An uncertainty of Ϯ2°may be assigned to the calculated diagram. 
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⌬ f G o ϭϪ37 384ϩ87.0660T J mol Ϫ1 .
͑116͒
The calculated phase diagram appears in Fig. 50 
Khellin "A…؉Sulfacetamide "B…
Data were obtained by DSC, DTA and thermal microscopy. 82 Samples were also examined by photomicroscopy. There is a 1:1 compound melting incongruently ( P ϭ149°C, x B ϭ0.45; Eϭ137.5°C, x B ϭ0.21). A metastable eutectic at 124°C was also reported. As presented, the RHS liquidus data impart a peculiar kinked shape to the curve there; the RHS data, in fact, suggest strong positive nonideality in the liquid. The LHS liquidus is normal. The quantity
allowed the RHS liquidus kink to be approximated. For the compound AB/2,
The calculated phase diagram is shown in Fig. 51 . Calculated data are Eϭ137.6°C, x B ϭ0.198 and Pϭ149.0°C, x B ϭ0.472. The true shape of the RHS liquidus may be different. An uncertainty of Ϯ3°may be assigned to the calculated diagram. 
for the compound AB/2. The calculated phase diagram is shown in Fig. 52 , with calculated invariant points E ϭ159.1°C, x B ϭ0.826 and Pϭ165.0°C, x B ϭ0.766. An uncertainty of Ϯ2°may be assigned to the calculated diagram.
Caffeine "A…؉Paracetamol "B…
Data were obtained by DSC and light transmission. 72 X-ray diffractograms of solid samples showed the system to be a simple eutectic (Eϭ142°C, x B ϭ0.64). Upon optimization, most liquidus data proved to lie rather low to be consistent with the reported eutectic temperature. The phase diagram, Fig. 53 , was calculated with the use of Eq. ͑123͒
and the calculated eutectic is 141.0°C, x B ϭ0.619. An uncertainty of Ϯ3°may be assigned to the calculated diagram. 
2-Nitroaniline "A…؉4-Aminobenzoic Acid "B…
Data were obtained by the thaw-melt method 57 on physical, fused and solvent-evaporated mixtures ͑only data from fused and solvent-evaporated mixtures are shown in the phase diagram͒. No invariant points were stated. All liquidus data were optimized to give
and the phase diagram calculated with this expression is shown in Fig. 57 . The calculated eutectic is 69.0°C, x B ϭ0.052. An uncertainty of Ϯ2°may be assigned to the calculated diagram.
Succinimide "A…؉Urea "B…
Data were obtained by DTA, 79 and the reported eutectic temperatures are 110 and 107°C. There is a congruently melting 1:1 compound. The data were fitted well by the expression
for the liquid and for the compound AB/2. The calculated diagram is shown in Fig. 58 and calculated data are E 1 ϭ110.0°C, x B ϭ0.149 and E 2 ϭ107.1°C, x B ϭ0.855. The compound melts at 130.4°C. The excess Gibbs energy of the liquid, Eq. ͑136͒, is very negative and the entropy of fusion of the compound, Eq. ͑137͒, is rather large compared to other systems examined in this work. Nevertheless the experimental data are faithfully reproduced. An uncertainty of Ϯ1°may be assigned to the calculated diagram.
Chlormadinone Acetate "A…؉Ethinyl
Estradiol "B… Data were obtained by DSC, light transmission and thermal microscopy. 54 The results of of these three methods are concordant. The presence of a 1:1 compound was confirmed by x-ray diffraction on solid samples, as well as by photomicrographic examination. A peritectic temperature of 170°C and a eutectic 160°C, x B ϭ0.75 were reported. Thermal events near 140°C were attributed to metastable transitions. From the experimental data it is difficult, if not impossible, to decide whether the compound melts congruently or incongruently. Optimization of the liquidus data resulted in Eq. ͑139͒
for the liquid and ⌬ fus G o ϭ20 004Ϫ45.1648T J mol Ϫ1 , ͑140͒ ⌬ f G o ϭϪ20 292ϩ39.4036T J mol Ϫ1 ͑141͒
for the compound AB/2. The calculated phase diagram is shown in Fig. 59 . The compound is shown to melt congruently at 169.74°C, but the E 1 eutectic (169.70°C, x B ϭ0.488) is so close that the congruency of melting of the compound is still uncertain. On the RHS, E 2 ϭ159.5°C, x B ϭ0.715. An uncertainty of Ϯ2°may be assigned to the calculated diagram.
Estradiol Benzoate "A…؉Estradiol
Phenylpropionate "B… Data were obtained by DSC and thermomicroscopy. 56 The reported eutectic is 118°C, x B ϭ0.85. This temperature corresponds to thermal arrests from DSC; those from thermal microscopy were slightly lower. The liquidus data from the two methods were generally concordant within 1°. The liquidus data, when optimized, yielded the quantity
and the phase diagram, calculated by means of this equation, is shown in Fig. 60 . The liquidus data are fitted well, and the calculated eutectic is 120.4°C, x B ϭ0.837. The calculated eutectic temperature is significantly higher than the experimental datum, but is thermodynamically consistent with the liquidus data. In this case, the liquidus data were taken as the defining data. An uncertainty of Ϯ2°may be assigned to the calculated diagram.
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